A global diversified life sciences company needed to protect its market share for a market-leading gastro-intestinal drug. With the product facing patent expiry in Europe and five competitors capable of producing a similar or substitute product, Fuld + Company provided competitive and market intelligence that will enable the company to defend the product franchise from current competitors as well as future, novel products.